Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Pilocarpine hydrochloride 40 mg/mL
Novartis New Zealand Ltd
Pilocarpine hydrochloride 40 mg/mL
4 %
Eye drops, solution
Active: Pilocarpine hydrochloride 40 mg/mL Excipient: Benzalkonium chloride Boric acid Hypromellose Purified water Sodium citrate dihydrate
Bottle, dropper, LDPE with PP cap; 1 x 15 mL, 15 mL
Prescription
Prescription
Anidro do Brazil Extracoes S.A.
Pilocarpine hydrochloride is a miotic (parasympathomimetic) used to control intraocular pressure. It may be used in combination with other miotics, beta blockers, carbonic anhydrase inhibitors, sympathomimetics, or hyperosmotic agents.
Package - Contents - Shelf Life: Bottle, dropper, LDPE with PP cap - 15 mL - 36 months from date of manufacture stored at or below 25°C 4 weeks opened stored at or below 25°C
1968-02-09
ISOPTO CARPINE ® EYE DROPS 1 ISOPTO CARPINE ® EYE DROPS _1%, 2% AND 4% _ _Pilocarpine hydrochloride _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU USE ANY ISOPTO CARPINE EYE DROPS. This leaflet answers some common questions about ISOPTO CARPINE. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. YOU CAN ALSO DOWNLOAD THE MOST UP TO DATE LEAFLET IN AUSTRALIA FROM WWW.NOVARTIS.COM.AU AND FROM WWW.MEDSAFE.GOVT.NZ IN NEW ZEALAND. The updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the expected benefits of you using ISOPTO CARPINE against the risks this medicine could have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ISOPTO CARPINE IS USED FOR ISOPTO CARPINE is used to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symp Read the complete document
Internal document code 1 iso200921iNZ NEW ZEALAND DATA SHEET 1. PRODUCT NAME ISOPTO ® CARPINE pilocarpine hydrochloride eye drops 1% ISOPTO ® CARPINE pilocarpine hydrochloride eye drops 2% ISOPTO ® CARPINE pilocarpine hydrochloride eye drops 4% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL of Isopto Carpine contains the active ingredient pilocarpine hydrochloride 1%, 2% or 4%. Excipient with known effect Benzalkonium chloride is included as a preservative. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Sterile eye drop solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pilocarpine hydrochloride is a miotic (parasympathomimetic) used to control intraocular pressure. It may be used in combination with other miotics, beta blockers, carbonic anhydrase inhibitors, sympathomimetics, or hyperosmotic agents. 4.2 DOSE AND METHOD OF ADMINISTRATION Instill two drops topically in the eye(s) up to three or four times daily. Under selected conditions, more frequent instillations may be indicated. Individuals with heavily pigmented irides may require larger doses. Method of administration Isopto Carpine is for ocular use. Discard eye drops four weeks after opening. 4.3 CONTRAINDICATIONS Miotics are contraindicated in conditions where papillary constriction is undesirable such as in acute iritis or anterior uveitis and in pupillary block glaucoma. Hypersensitivity to any of the components listed under section 6.1 List of excipients 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For topical use only. NOT FOR INJECTION. Information for Patients Retinal detachment has been reported when miotics are used in susceptible individuals, such as young patients with myopia or patients with history of retinal detachment. Miotics should be avoided in acute inflammatory diseases of the anterior chamber . A paradoxical rise in intraocular pressure may be observed in patients with severely Internal document code 2 iso200921iNZ compromised trabecular outflow. Caution is advised in the presence of corne Read the complete document